✦ LIBER ✦

Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study

✍ Scribed by M.-S Choo; J. Z. Lee; J. B. Lee; Y.-H. Kim; H. C. Jung; K.-S. Lee; J. C. Kim; J. T. Seo; J.-S. Paick; H.-J. Kim; Y. G. Na; J. G. Lee

Book ID: 111308844
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 251 KB
Volume: 62
Category: Article
ISSN: 1368-5031
DOI: 10.1111/j.1742-1241.2008.01898.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination Treatment with Mirabegron an

Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony)

✍ Abrams, Paul; Kelleher, Con; Staskin, David; Rechberger, Tomasz; Kay, Richard; M 📂 Article 📅 2015 🏛 Elsevier Science 🌐 English ⚖ 688 KB

S20 DUDASTERIDE AND SOLIFENACIN SUCCINAT

S20 DUDASTERIDE AND SOLIFENACIN SUCCINATE FOR SAFETY AND EFFICACY IN PATIENTS OVERACTIVE BLADDER WITH PROSTATE ≥ 30 GRAMS

✍ K. Drasa; R. Katroshi; A. Braho 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Efficacy and safety of solifenacin succi

Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder

✍ Franklin Chu; Neila Smith; Takeshi Uchida 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

RANDOMIZED, DOUBLE-BLIND PLACEBO CONTROL

RANDOMIZED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF THE ONCE DAILY ANTIMUSCARINIC AGENT SOLIFENACIN SUCCINATE IN PATIENTS WITH OVERACTIVE BLADDER

✍ CARDOZO, L.; LISEC, M.; MILLARD, R.; van VIERSSEN TRIP, O.; KUZMIN, I.; DROGENDI 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 793 KB

Efficacy and Safety of Propiverine and S

Efficacy and Safety of Propiverine and Solifenacin for the Treatment of Female Patients with Overactive Bladder: A Crossover Study

✍ Naoki WADA; Masaki WATANABE; Masafumi KITA; Hiroaki OSANAI; Satoshi YAMAGUCHI; A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 740 KB

Efficacy and Safety of Low Doses of Onab

Efficacy and Safety of Low Doses of OnabotulinumtoxinA for the Treatment of Refractory Idiopathic Overactive Bladder: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Dose-Ranging Study

✍ Pierre Denys; Loïc Le Normand; Idir Ghout; Pierre Costa; Emmanuel Chartier-Kastl 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 636 KB